176 related articles for article (PubMed ID: 7536856)
1. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
Levillain O; Marescau B; de Deyn PP
Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
[TBL] [Abstract][Full Text] [Related]
2. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
[TBL] [Abstract][Full Text] [Related]
3. Renal handling of guanidino compounds in rat and rabbit.
Levillain O; Marescau B; De Deyn PP
J Physiol; 1997 Mar; 499 ( Pt 2)(Pt 2):561-70. PubMed ID: 9080382
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice.
Al Banchaabouchi M; Marescau B; Van Marck E; D'hooge R; De Deyn PP
Metabolism; 2001 Dec; 50(12):1418-25. PubMed ID: 11735086
[TBL] [Abstract][Full Text] [Related]
5. Dehydration modifies guanidino compound concentrations in the different zones of the rat kidney.
Levillain O; Marescau B; Possemiers I; De Deyn P
Pflugers Arch; 2002 May; 444(1-2):143-52. PubMed ID: 11976926
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and distribution of pharmacological homoarginine in plasma and main organs of the anesthetized rat.
Günes DN; Kayacelebi AA; Hanff E; Lundgren J; Redfors B; Tsikas D
Amino Acids; 2017 Dec; 49(12):2033-2044. PubMed ID: 28710553
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and histopathological changes in nephrectomized mice.
Al Banchaabouchi M; Marescau B; D'Hooge R; Van Marck E; Van Daele A; Levillain O; De Deyn PP
Metabolism; 1998 Mar; 47(3):355-61. PubMed ID: 9500577
[TBL] [Abstract][Full Text] [Related]
8. Guanidino compound levels in brain regions of non-dialyzed uremic patients.
De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C
Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of arginine by the isolated perfused rat kidney.
Perez GO; Epstein M; Rietberg B; Loutzenhiser R
Am J Physiol; 1978 Oct; 235(4):F376-80. PubMed ID: 696875
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous stable-isotope dilution GC-MS measurement of homoarginine, guanidinoacetate and their common precursor arginine in plasma and their interrelationships in healthy and diseased humans.
Hanff E; Kayacelebi AA; Yanchev GR; Maassen N; Haghikia A; Tsikas D
Amino Acids; 2016 Mar; 48(3):721-732. PubMed ID: 26573540
[TBL] [Abstract][Full Text] [Related]
11. Concentrations in serum and urinary excretion of guanidine, 1-methylguanidine, and 1,1-dimethylguanidine in chronic renal failure.
Stein IM; Micklus MJ
Clin Chem; 1973 Jun; 19(6):583-5. PubMed ID: 4705174
[No Abstract] [Full Text] [Related]
12. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
[TBL] [Abstract][Full Text] [Related]
13. Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction.
Verhelst J; Berwaerts J; Marescau B; Abs R; Neels H; Mahler C; De Deyn PP
Metabolism; 1997 Sep; 46(9):1063-7. PubMed ID: 9284897
[TBL] [Abstract][Full Text] [Related]
14. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency.
Marescau B; Nagels G; Possemiers I; De Broe ME; Becaus I; Billiouw JM; Lornoy W; De Deyn PP
Metabolism; 1997 Sep; 46(9):1024-31. PubMed ID: 9284891
[TBL] [Abstract][Full Text] [Related]
15. Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy.
Marescau B; De Deyn PP; Lowenthal A; Qureshi IA; Antonozzi I; Bachmann C; Cederbaum SD; Cerone R; Chamoles N; Colombo JP
Pediatr Res; 1990 Mar; 27(3):297-303. PubMed ID: 1690873
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure.
Sawynok J; Dawborn JK
Clin Exp Pharmacol Physiol; 1975; 2(1):1-15. PubMed ID: 1126056
[TBL] [Abstract][Full Text] [Related]
17. Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans.
Derave W; Marescau B; Vanden Eede E; Eijnde BO; De Deyn PP; Hespel P
J Appl Physiol (1985); 2004 Sep; 97(3):852-7. PubMed ID: 15107411
[TBL] [Abstract][Full Text] [Related]
18. Guanidino compounds in hyperargininemia.
Mizutani N; Hayakawa C; Ohya Y; Watanabe K; Watanabe Y; Mori A
Tohoku J Exp Med; 1987 Nov; 153(3):197-205. PubMed ID: 3433275
[TBL] [Abstract][Full Text] [Related]
19. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
[TBL] [Abstract][Full Text] [Related]
20. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
